Home » Stocks » CMD

Cantel Medical Corporation (CMD)

Stock Price: $83.92 USD 0.52 (0.62%)
Updated May 13, 2021 2:45 PM EDT - Market open
Market Cap 3.75B
Revenue (ttm) 1.06B
Net Income (ttm) 46.74M
Shares Out 42.24M
EPS (ttm) 1.09
PE Ratio 77.06
Forward PE 40.49
Dividend n/a
Dividend Yield n/a
Trading Day May 13
Last Price $83.92
Previous Close $83.40
Change ($) 0.52
Change (%) 0.62%
Day's Open 83.76
Day's Range 83.55 - 84.26
Day's Volume 142,072
52-Week Range 29.74 - 89.76

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

PLYMOUTH, Minn.--(BUSINESS WIRE)-- #Hemodialysis--Mar Cor launches the EON Portable RO Dialysis Water System. It produces high-quality medical water for acute and home hemodialysis use.

1 week ago - Business Wire

Cantel (CMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

2 weeks ago - Zacks Investment Research

Cantel (CMD), Hill-Rom (HRC), LeMaitre (LMAT) and Masimo (MASI) can prove to be prudent investment choices in the critical care industry of the MedTech sector.

Other stocks mentioned: HRC, LMAT, MASI, RMD
1 month ago - Zacks Investment Research

Cantel (CMD) possesses solid growth attributes, which could help it handily outperform the market.

1 month ago - Zacks Investment Research

Cantel (CMD) could produce exceptional returns because of its solid growth attributes.

2 months ago - Zacks Investment Research

NEW YORK, March 11, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cantel Medical Corp. (NYSE: CMD) concerning potential...

Other stocks mentioned: COHR, CUB, PAND, PRSP
2 months ago - PRNewsWire

CMD vs. ABMD: Which Stock Is the Better Value Option?

Other stocks mentioned: ABMD
2 months ago - Zacks Investment Research

Cantel (CMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

2 months ago - Zacks Investment Research

Cantel (CMD) delivered earnings and revenue surprises of 61.22% and 9.39%, respectively, for the quarter ended January 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Cantel Medical (NYSE:CMD) announces its next round of earnings this Tuesday, March 09. Here is Benzinga's everything-that-matters guide for this Tuesday's Q2 earnings announcement.

2 months ago - Benzinga

Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

LITTLE FALLS, N.J., Feb. 25, 2021 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its second quarter ended January 31, 2021 on Tuesday, March 9, 2021 before the market opens...

2 months ago - PRNewsWire

NEW ORLEANS, Feb. 9, 2021 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Cantel...

Other stocks mentioned: STE
3 months ago - PRNewsWire

WILMINGTON, Del., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating Cantel Medical Corp. (“Cantel”) (NYSE: CMD) regarding possible breaches of fiduciary duties and...

3 months ago - GlobeNewsWire

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cantel Medical Cor...

Other stocks mentioned: STE
3 months ago - Business Wire

NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York Cit...

3 months ago - PRNewsWire

Does Cantel Medical (CMD) have what it takes to be a top stock pick for momentum investors? Let's find out.

4 months ago - Zacks Investment Research

STERIS (STE) expects to strengthen and expand its endoscopy offerings along with extending into a new customer territory via the Cantel Medical buyout.

Other stocks mentioned: STE
4 months ago - Zacks Investment Research

NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cantel Medical Corp. (NYSE: CMD) concerning potential ...

4 months ago - PRNewsWire

NEW YORK, Jan. 12, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Cantel Medical Corp. ("CMD" or the "Com...

4 months ago - PRNewsWire

NEW YORK, Jan. 12, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Cantel Medical Corporation (NYSE: CMD) ("Cantel") and its board of directors concerning th...

Other stocks mentioned: STE
4 months ago - PRNewsWire

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether Cantel Medical Corp. (NYSE: CMD) and its board of directors violated the federal securities laws ...

4 months ago - Business Wire

Shares of Cantel Medical Corp. rose 1.8% in premarket trading Tuesday, after the infection prevention products company announced an agreement to be acquired by Ireland-based Steris PLC in a cash and equ...

Other stocks mentioned: STE
4 months ago - Market Watch

Top Ranked Momentum Stocks to Buy for December 23rd

Other stocks mentioned: BIDU, TSE
4 months ago - Zacks Investment Research

Cantel (CMD) possesses solid growth attributes, which could help it handily outperform the market.

4 months ago - Zacks Investment Research

Top Ranked Momentum Stocks to Buy for December 21st

Other stocks mentioned: EVR, RIO
4 months ago - Zacks Investment Research

Cantel (CMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

4 months ago - Zacks Investment Research

Cantel Medical Corp. (CMD) CEO George Fotiades on Q1 2021 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

iBio (NYSE: IBIO) shares are trading lower on Tuesday after the company announced a common stock offering. iBio's main area of business is plant-based protein expression technologies for vaccines and th...

Other stocks mentioned: IBIO, STRO
5 months ago - Benzinga

The company's latest quarterly earnings report managed to impress investors.

5 months ago - The Motley Fool

Cantel (CMD) delivered earnings and revenue surprises of 150.00% and 1.55%, respectively, for the quarter ended October 2020. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Shares of Cantel Medical (NYSE:CMD) were unchanged in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 38.46% over the past year to $0.90, which beat t...

5 months ago - Benzinga

LITTLE FALLS, N.J., Dec. 8, 2020 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its first quarter ended October 31, 2020. First quarter 2021 net sales were $297.0...

5 months ago - PRNewsWire

LITTLE FALLS, N.J., Dec. 7, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) and Censis Technologies announced today a new long-term partnership to combine Cantel's leading infection prevention endo...

5 months ago - PRNewsWire

FRANKLIN, Tenn.--(BUSINESS WIRE)--Today, Censis Technologies, a wholly owned subsidiary of Fortive Corporation, and Cantel Medical Corp announced a new long-term partnership to combine Cantel's leading ...

5 months ago - Business Wire

Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

Cantel Medical has the legs to reach historical growth levels over the coming periods, backed by a strong Q4 performance. Q1 pre-announcements have indicated a stronger than expected sales recovery, and...

5 months ago - Seeking Alpha

Cantel (CMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

6 months ago - Zacks Investment Research

COVID-19 has heightened the demand for companies that specialize in infection control.

Other stocks mentioned: JNJ, STE
6 months ago - The Motley Fool

The Covid-19 pandemic has given a significant boost to many industries such as manufacturers of gloves, masks, sanitizers, PPE (personal protective equipment), health insurance providers, and many more ...

Other stocks mentioned: CLX, ECL, KMB, NEOG, SNOA
6 months ago - GuruFocus

CHICAGO, Oct. 1, 2020 /PRNewswire/ -- HuFriedyGroup, the dental division of Cantel Medical Corp. (NYSE: CMD), and a global leader in infection prevention, dental instrument manufacturing, and instrument...

7 months ago - PRNewsWire

Cantel Medical Corp. (CMD) CEO George Fotiades on Q4 2020 Results - Earnings Call Transcript

7 months ago - Seeking Alpha

Cantel (CMD) delivered earnings and revenue surprises of 200.00% and 0.14%, respectively, for the quarter ended July 2020. Do the numbers hold clues to what lies ahead for the stock?

7 months ago - Zacks Investment Research

Shares of Cantel Medical (NYSE:CMD) moved higher by 4.9% in pre-market trading after the company reported Q4 results.

7 months ago - Benzinga

LITTLE FALLS, N.J., Sept. 17, 2020 /PRNewswire/ -- Cantel Medical Corp.

7 months ago - PRNewsWire

Cantel Medical (NYSE: CMD) announces its next round of earnings this Thursday, September 17.

7 months ago - Benzinga

Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

8 months ago - Zacks Investment Research

LITTLE FALLS, N.J., Sept. 3, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP.

8 months ago - PRNewsWire

LITTLE FALLS, N.J., Aug. 6, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP.

9 months ago - PRNewsWire

LITTLE FALLS, N.J., Aug. 3, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP.

9 months ago - PRNewsWire

About CMD

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its... [Read more...]

Industry
Medical Instruments & Supplies
Founded
1963
CEO
George Fotiades
Employees
3,669
Stock Exchange
NYSE
Ticker Symbol
CMD
Full Company Profile

Financial Performance

In 2020, Cantel Medical's revenue was $1.02 billion, an increase of 10.66% compared to the previous year's $918.16 million. Earnings were $13.71 million, a decrease of -75.10%.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for Cantel Medical stock is "Hold." The 12-month stock price forecast is 62.00, which is a decrease of -26.12% from the latest price.

Price Target
$62.00
(-26.12% downside)
Analyst Consensus: Hold